Published in Can J Ophthalmol on July 01, 1972
Accuracy of clinical diagnosis in parkinsonism--a prospective study. Can J Neurol Sci (1991) 2.26
The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol (2000) 2.08
Parkinsonism as a manifestation of brain tumor. Surg Neurol (1985) 1.79
Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry (1984) 1.69
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol (1982) 1.36
Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol (1984) 1.34
Prevalence of movement disorders in elderly community residents. Neuroepidemiology (1994) 1.31
Neuroaxonal dystrophy. A case of delayed onset and protracted course. Acta Neuropathol (1971) 1.24
Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry (1976) 1.21
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology (2001) 1.20
Extradural hematoma following frontal sinusitis. Report of a case and review of the literature. Arch Otolaryngol (1971) 1.16
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology (1999) 1.16
Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol (1989) 1.14
Western encephalitis: report of eight fatal cases. Saskatchewan epidemic, 1965. Can Med Assoc J (1968) 1.14
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biol Psychiatry (2001) 1.12
Cyanide-induced parkinsonism: a clinicopathologic report. Neurology (1985) 1.10
Relative efficacy of alcohol and propranolol in action tremor. Can J Neurol Sci (1975) 1.09
Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology (1984) 1.07
Environmental toxins accelerate Parkinson's disease onset. Neurology (2001) 1.06
Clinicopathologic observations in essential tremor: report of six cases. Neurology (1991) 1.05
GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia. Ann Neurol (1996) 1.04
Identification of FUS p.R377W in essential tremor. Eur J Neurol (2013) 1.03
Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol (1990) 1.02
Shy-Drager syndrome. Report of an autopsied case. Neurology (1971) 1.01
Nervous system complications of relapsing polychondritis. Neurology (1983) 0.98
Striatonigral degeneration response to levodopa therapy. J Neurol Sci (1972) 0.97
Primary progressive multifocal leukoencephalopathy. A case report. Neurology (1971) 0.97
Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Res (1994) 0.97
A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology (1987) 0.95
Tourette syndrome in Rochester, Minnesota, 1968-1979. Adv Neurol (1982) 0.95
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology (1996) 0.93
Pulmonary embolism: an under-recognized yet frequent cause of death in parkinsonism. Mov Disord (1994) 0.92
Central nervous system involvement in rheumatoid disease. Report of a case. Neurology (1967) 0.91
Decadron in the treatment of cerebral abscess. An experimental study. J Neurosurg (1976) 0.90
Astroblastoma revisited: a report of three cases. Acta Neuropathol (1986) 0.90
Spontaneous dissecting aneurysm of the internal carotid artery in the neck. Report of a case and review of the literature. Arch Neurol (1970) 0.90
Early onset Parkinson's disease in Saskatchewan--environmental considerations for etiology. Can J Neurol Sci (1986) 0.89
Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains. Can J Neurol Sci (1989) 0.87
Hemorrhagic changes in experimental spinal cord injury models. Can J Neurol Sci (1985) 0.87
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience (2001) 0.86
Muscular dystrophy in Saskatchewan Hutterites. Am J Med Genet (1985) 0.86
The role of neomembranes in formation of hematoma around Silastic dura substitute. Case report. J Neurosurg (1983) 0.86
Shy-Drager syndrome: the transitional variant. Clin Neuropathol (1987) 0.86
Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss. Ann Neurol (1986) 0.86
Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Arch Neurol (1984) 0.85
Timely levodopa (LD) administration prolongs survival in Parkinson's disease. Parkinsonism Relat Disord (1997) 0.84
Drug induced dystonia tarda: treatment with L-dopa. Dis Nerv Syst (1973) 0.84
Significance of parkinsonian manifestations in essential tremor. Can J Neurol Sci (1993) 0.84
Levodopa in dystonia musculorum deformans. Lancet (1973) 0.84
Fahr's disease associated with astrocytic proliferation and astrocytoma. Surg Neurol (1993) 0.84
Serum antioxidant enzyme activity in Parkinson's disease. Mol Cell Biochem (1992) 0.84
Prevalence of movement disorders in institutionalized elderly. Neuroepidemiology (1995) 0.83
Amantadine-dyazide interaction. Can Med Assoc J (1983) 0.83
Familial holoprosencephaly. Dev Med Child Neurol (1970) 0.83
Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain. Biol Psychiatry (1978) 0.82
Occurrence of resting tremor in Parkinson's disease. Neurology (1991) 0.82
Nuclear jaundice (kernicterus) in a newborn kitten. J Am Vet Med Assoc (1970) 0.80
Crigler-Najjar syndrome in four of five siblings with postmortem findings in one. Arch Pathol (1970) 0.80
New use for an old drug: amantadine benefits levodopa-induced dyskinesia. Mov Disord (1998) 0.80
Observations in five cases of spontaneous cerebellar hemorrhage. Can Med Assoc J (1972) 0.80
Multicore disease in sibs with severe mental retardation, short stature, facial anomalies, hypoplasia of the pituitary fossa, and hypogonadotrophic hypogonadism. Am J Med Genet (1985) 0.80
Hallervorden-Spatz disease. Late infantile and adult types, report of two cases. Acta Neuropathol (1968) 0.80
Herpes simplex encephalitis: two fatal cases. Can Med Assoc J (1967) 0.80
Spinal extradural angiolipoma. A case report and literature review. Spine (Phila Pa 1976) (1986) 0.80
Vernix caseosa meningitis and laryngeal stridor in an infant with myelomeningocele. Case report. J Neurosurg (1975) 0.80
Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol (1988) 0.80
An independent replication of PARK16 in Asian samples. Neurology (2010) 0.80
What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord (1993) 0.79
Congenital hydrocephalus secondary to intra-uterine germinal matrix/intraventricular haemorrhage. Dev Med Child Neurol (1984) 0.79
GABA-dopamine relationship in Parkinson's disease striatum. Adv Neurol (1987) 0.79
Progressive supranuclear palsy: clinical features, pathophysiology and management. Drugs Aging (2001) 0.79
Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease. Mol Cell Biochem (1992) 0.79
Primary intracranial chondrosarcoma: a report of two cases. Neurosurgery (1985) 0.79
Early onset Parkinson's disease and childhood environment. Adv Neurol (1987) 0.79
Alzheimer's disease and idiopathic Parkinson's disease coexistence. J Geriatr Psychiatry Neurol (1993) 0.79
Epidemiological survey of dementia in parkinsonism and control population. Adv Neurol (1984) 0.78
Epidemiology of Parkinson's disease. Can J Neurol Sci (1984) 0.78
Age, environments, and the number of substantia nigra neurons. Adv Neurol (1990) 0.78
Malignant intracranial fibrous histiocytomas. Histologic, ultrastructural and immunohistochemical studies of two cases. Can J Neurol Sci (1986) 0.77
Supratentorial capillary hemangioblastoma presenting with fatal spontaneous intracerebral hemorrhage. Neurosurgery (1983) 0.77
Paraquat and Parkinson's disease. Neurology (1987) 0.77
Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case. Mov Disord (1997) 0.77
Frequency of respiratory disorders and bradycardia in essential tremor - consideration of treatment. Parkinsonism Relat Disord (1998) 0.77
Purkinje cell loss is neither pathological basis nor characteristic of essential tremor. Parkinsonism Relat Disord (2013) 0.77
Parkinson's disease and essential tremor. Neurology (1994) 0.77
Death-associated protein kinase 1 variation and Parkinson's disease. Eur J Neurol (2010) 0.76
Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme. Brain Res (1997) 0.76
Postural hypotension in idiopathic Parkinson's disease. Etiopathology. Neurol Neurocir Psiquiatr (1976) 0.76
Vascular pathology in male Lewis rats following short-term, low-dose rotenone administration. Vet Pathol (2009) 0.76
Inhibition of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by deprenyl. Life Sci (1996) 0.76
Neurological disorders and services in Saskatchewan--a report based on provincial health care records. Neuroepidemiology (1988) 0.75
Parkinson's disease risk factors. Neurology (1994) 0.75
Polyneuropathy. Can Fam Physician (1974) 0.75